---

$5.03

-0.2490 ( -4.72% ) 3.9K

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-06	Buy	166666.00	Climaco John M
2024-02-06	Buy	33333.00	Evans Carl Anthony
2024-02-06	Buy	33333.00	Gumulka Jerzy
2024-02-06	Sale	-12420.00	Mahery Amy
2023-09-25	Sale	-68961.00	Andraczke Andrzej
2023-09-25	Sale	-45974.00	Charles Faith L.
2023-09-25	Sale	-16551.00	Cockroft Bettina M.
2023-09-25	Sale	-68961.00	Evans Carl Anthony
2023-09-25	Sale	-68961.00	Gumulka Jerzy
2023-09-25	Sale	-68961.00	Keyes Jeffry R.